Norlase
DenmarkEntry
2021
Hold
5yr
Status
Active
Who owns Norlase?
Norlase is a Danish MedTech company, currently owned by Nordic Secondary Fund since 2021 and Spring Nordic.
Hand-verified · updated 2026-08-19
Open JSON · CC-BYMost recent investor
Nordic Secondary FundNordic Secondary Fund I · 2018 · Secondaries
2 ownership periods · full history below
Key facts
HQDenmark
SectorMedTech
StatusActive
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2014 · present
Spring NordicActive
2014 · present(12yr) · Spring Nordic · 2010 · VC
Nordic Secondary FundActive
2021 · present(5yr) · Nordic Secondary Fund I · 2018 · Secondaries
More from Nordic Secondary Fund I
Other portfolio companies in the same fund.
Sweden
FinlandMore PE-backed in MedTech
Comparable medtech deals from other GPs.
US
GermanyQuestions
Who owns Norlase?
Norlase is currently owned by Nordic Secondary Fund and Spring Nordic, through Nordic Secondary Fund I, since 2021.
When did Nordic Secondary Fund and 1 other acquire Norlase?
Nordic Secondary Fund and 1 other acquired Norlase in 2021.
Who has owned Norlase over time?
Norlase has been through 2 private-equity ownership periods: Spring Nordic · via Spring Nordic · since 2014; Nordic Secondary Fund · via Nordic Secondary Fund I · since 2021.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue